Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates.

Authors:
Wang Y; Fang S; Wu Y; Cheng X; Zhang LK and 6 more

Journal:
Acta Pharmacol Sin

Publication Year: 2021

DOI:
10.1038/s41401-021-00732-2

PMCID:
PMC8295639

PMID:
34294887

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Acta Pharmacol Sin

Abbreviation: Acta Pharmacol Sin

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A dual role of lysophosphatidic acid type 2 receptor (LPAR2) in nonsteroidal anti-inflammatory drug…
Hutka B; Várallyay A; László SB and 12 more (2023) - Transparency Score: 4/6
Cynaropicrin disrupts tubulin and c-Myc-related signaling and induces parthanatos-type cell death i…
Boulos JC; Omer EA; Rigano D and 6 more (2023) - Transparency Score: 3/6
GPR84 regulates pulmonary inflammation by modulating neutrophil functions.
Wang SW; Zhang Q; Lu D and 9 more (2023) - Transparency Score: 3/6
Inhibiting the transcription and replication of Ebola viruses by disrupting the nucleoprotein and V…
Ma YH; Hong X; Wu F and 7 more (2023) - Transparency Score: 3/6
MANF ameliorates DSS-induced mouse colitis via restricting Ly6C<sup>hi</sup>CX3CR1<sup>int</sup> ma…
Yang L; Shen WW; Shao W and 7 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"We are grateful to the National Science Fund of Distinguished Young Scholars (81825021), Fund of Youth Innovation Promotion Association (2019285), the National Natural Science Foundation of China (81773707, 31700732), Fund of Shanghai Science and Technology Innovation Action Plan (20ZR1474200), the National Key Research and Development Program of China (2020YFC0842000), the Strategic Leading Science and Technology Projects of Chinese Academy of Sciences (XDA12050308), Fund of National Science and Technology Major Project (2018ZX09711002-002-006) and the Hubei Science and Technology Project (2020FCA003) for financial support."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025